Literature DB >> 19233546

Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.

Anna Pokryszko-Dragan1, Mieszko Zagrajek, Krzysztof Slotwinski, Ewa Gruszka, Małgorzata Bilinska, Ryszard Podemski.   

Abstract

AIMS: The aim of the study was to evaluate cognitive impairment in multiple sclerosis (MS) patients using neuropsychological testing (NT) and auditory event-related potentials (ERPs) with reference to clinical variables, with an attempt to re-assess NT and ERP results after a year.
METHODS: The study comprised 21 patients with MS. ERPs results were compared to age-matched controls. Correlations were searched among ERPs and NT results, duration of MS and disability. NT and ERPs were repeated after a year and their results were compared with the initial ones.
RESULTS: In NT, 90-100% of patients showed impaired memory and attention. Latencies of ERPs were prolonged in patients compared with controls. NT results correlated with clinical variables and N2 parameters. Results of NT, but not ERPs, improved after a year.
CONCLUSIONS: MS patients present with moderate cognitive impairment and ERP abnormalities, with dysfunction of subcortical-prefrontal circuit as their possible background. NT are more useful than ERP in monitoring cognitive performance in MS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233546     DOI: 10.1016/j.clineuro.2009.01.009

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study.

Authors:  S Lori; E Portaccio; V Zipoli; M Giannini; S Scarpelli; B Goretti; M P Amato
Journal:  Neurol Sci       Date:  2011-05-17       Impact factor: 3.307

2.  Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.

Authors:  Anna Pokryszko-Dragan; Mieszko Zagrajek; Krzysztof Slotwinski; Malgorzata Bilinska; Ewa Gruszka; Ryszard Podemski
Journal:  Neurol Sci       Date:  2016-06-06       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.